应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GNPX Genprex, Inc.
休市中 03-14 16:00:00 EDT
0.3633
+0.0032
+0.89%
盘后
0.3750
+0.0117
+3.22%
19:59 EDT
最高
0.3700
最低
0.3465
成交量
100.42万
今开
0.3600
昨收
0.3601
日振幅
6.53%
总市值
309.10万
流通市值
308.22万
总股本
850.81万
成交额
35.89万
换手率
11.84%
流通股本
848.38万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Genprex, Inc.盘中异动 大幅上涨5.33%报0.395美元
市场透视 · 02-28
Genprex, Inc.盘中异动 大幅上涨5.33%报0.395美元
Genprex, Inc.盘中异动 早盘股价大涨5.44%
市场透视 · 02-26
Genprex, Inc.盘中异动 早盘股价大涨5.44%
Genprex, Inc.盘中异动 早盘急速下挫5.88%
市场透视 · 02-24
Genprex, Inc.盘中异动 早盘急速下挫5.88%
Genprex, Inc.盘中异动 早盘大幅下挫5.27%
市场透视 · 02-19
Genprex, Inc.盘中异动 早盘大幅下挫5.27%
Genprex, Inc.盘中异动 股价大跌5.65%
市场透视 · 02-18
Genprex, Inc.盘中异动 股价大跌5.65%
Genprex, Inc.股价拉升12.82% 市值涨58.55万美元
市场透视 · 02-13
Genprex, Inc.股价拉升12.82% 市值涨58.55万美元
Genprex, Inc.盘中异动 早盘大幅上涨5.80%报0.529美元
市场透视 · 02-06
Genprex, Inc.盘中异动 早盘大幅上涨5.80%报0.529美元
Genprex, Inc.股价重挫12.31% 市值跌5.99万美元
市场透视 · 02-04
Genprex, Inc.股价重挫12.31% 市值跌5.99万美元
Genprex, Inc.盘中异动 早盘大幅下挫5.08%报0.587美元
市场透视 · 02-04
Genprex, Inc.盘中异动 早盘大幅下挫5.08%报0.587美元
Genprex, Inc.盘中异动 股价大涨5.28%
市场透视 · 01-28
Genprex, Inc.盘中异动 股价大涨5.28%
Genprex, Inc.盘中异动 早盘快速下跌7.13%
市场透视 · 01-27
Genprex, Inc.盘中异动 早盘快速下跌7.13%
Genprex, Inc.盘中异动 大幅拉升6.01%
市场透视 · 01-23
Genprex, Inc.盘中异动 大幅拉升6.01%
Genprex, Inc.盘中异动 股价大跌5.15%报0.700美元
市场透视 · 01-16
Genprex, Inc.盘中异动 股价大跌5.15%报0.700美元
Genprex, Inc.盘中异动 早盘快速下挫5.15%报0.810美元
市场透视 · 01-08
Genprex, Inc.盘中异动 早盘快速下挫5.15%报0.810美元
Genprex, Inc.盘中异动 急速下挫6.09%报0.822美元
市场透视 · 01-07
Genprex, Inc.盘中异动 急速下挫6.09%报0.822美元
Genprex, Inc.盘中异动 早盘快速上涨5.05%报0.880美元
市场透视 · 01-06
Genprex, Inc.盘中异动 早盘快速上涨5.05%报0.880美元
Genprex, Inc.盘中异动 早盘股价大涨5.82%
市场透视 · 01-02
Genprex, Inc.盘中异动 早盘股价大涨5.82%
Genprex, Inc.盘中异动 股价大涨5.27%报0.895美元
市场透视 · 2024-12-31
Genprex, Inc.盘中异动 股价大涨5.27%报0.895美元
Genprex, Inc.盘中异动 早盘急速下挫5.16%
市场透视 · 2024-12-30
Genprex, Inc.盘中异动 早盘急速下挫5.16%
Genprex, Inc.盘中异动 早盘股价大跌5.09%
市场透视 · 2024-12-24
Genprex, Inc.盘中异动 早盘股价大跌5.09%
加载更多
公司概况
公司名称:
Genprex, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Genprex, Inc.于2009年4月在特拉华州注册成立。该公司是一家私人持有的临床阶段生物制药公司,为癌症开发免疫原性治疗。Genprex是一种临床阶段的基因治疗公司,开发一种新的方法来治疗癌症,根据其新的专利技术平台,包括其最初的候选产品,Oncoprex免疫基因治疗提供,或Oncoprex。他们的平台技术旨在通过将其包封在称为纳米囊泡的纳米尺度空心球体中来治疗癌症基因,然后静脉内施用并被肿瘤细胞摄取,其中它们表达缺少或发现量低的蛋白质。 Oncoprex具有多模式作用机制,其中断细胞信号通路,其引起癌细胞的复制和增殖,重新建立癌细胞中凋亡途径或程序性细胞死亡途径,并调节针对癌细胞的免疫应答。 Oncoprex也被证明可以阻断产生耐药性的机制。
发行价格:
--
{"stockData":{"symbol":"GNPX","market":"US","secType":"STK","nameCN":"Genprex, Inc.","latestPrice":0.3633,"timestamp":1741982400000,"preClose":0.3601,"halted":0,"volume":1004189,"hourTrading":{"tag":"盘后","latestPrice":0.375,"preClose":0.3633,"latestTime":"19:59 EDT","volume":74879,"amount":28007.2973,"timestamp":1741996748167},"delay":0,"floatShares":8483819,"shares":8508068,"eps":-10.343529,"marketStatus":"休市中","change":0.0032,"latestTime":"03-14 16:00:00 EDT","open":0.36,"high":0.37,"low":0.3465,"amount":358854.139185,"amplitude":0.06526,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.343529,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1742198400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1522296000000,"exchange":"NASDAQ","adjPreClose":0.3601,"preHourTrading":{"tag":"盘前","latestPrice":0.375,"preClose":0.3601,"latestTime":"09:28 EDT","volume":10661,"amount":3972.347875,"timestamp":1741958917359},"postHourTrading":{"tag":"盘后","latestPrice":0.375,"preClose":0.3633,"latestTime":"19:59 EDT","volume":74879,"amount":28007.2973,"timestamp":1741996748167},"volumeRatio":1.2456172820063078,"impliedVol":5.668,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/GNPX","defaultTab":"news","newsList":[{"id":"2514522378","title":"Genprex, Inc.盘中异动 大幅上涨5.33%报0.395美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514522378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514522378?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:38","pubTimestamp":1740753502,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时38分,Genprex, Inc.股票出现异动,股价大幅拉升5.33%。截至发稿,该股报0.395美元/股,成交量4.8375万股,换手率0.57%,振幅1.39%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223822a2580314&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223822a2580314&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2514851687","title":"Genprex, Inc.盘中异动 早盘股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514851687?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:53","pubTimestamp":1740581593,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时53分,Genprex, Inc.股票出现波动,股价大幅上涨5.44%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225313a254fc08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225313a254fc08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2513656773","title":"Genprex, Inc.盘中异动 早盘急速下挫5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513656773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513656773?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:47","pubTimestamp":1740412041,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时47分,Genprex, Inc.股票出现波动,股价快速下挫5.88%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.17%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234722a2522674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234722a2522674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2512848369","title":"Genprex, Inc.盘中异动 早盘大幅下挫5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512848369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512848369?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:44","pubTimestamp":1739976264,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时44分,Genprex, Inc.股票出现波动,股价急速跳水5.27%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224424988b33e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224424988b33e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2512165056","title":"Genprex, Inc.盘中异动 股价大跌5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512165056?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889100,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分,Genprex, Inc.股票出现波动,股价大幅跳水5.65%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223140a24aac82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223140a24aac82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2511851526","title":"Genprex, Inc.股价拉升12.82% 市值涨58.55万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511851526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511851526?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457068,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分,Genprex, Inc.股票出现异动,股价大幅拉升12.82%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。其相关个股中,Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 涨幅较大,Tc Biopharm Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃,换手率分别为970.17%、765.03%、89.78%,振幅较大的相关个股有Enliven Therapeutics, Inc.、Rezolute, Inc.、Edesa Biotech, Inc.,振幅分别为7.80%、4.53%、4.03%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223108abcdb1e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223108abcdb1e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2509327701","title":"Genprex, Inc.盘中异动 早盘大幅上涨5.80%报0.529美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509327701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509327701?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:31","pubTimestamp":1738852272,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时31分,Genprex, Inc.股票出现异动,股价大幅上涨5.80%。截至发稿,该股报0.529美元/股,成交量3.3096万股,换手率0.39%,振幅0.00%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223112987c8e9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223112987c8e9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2508457753","title":"Genprex, Inc.股价重挫12.31% 市值跌5.99万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508457753?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:33","pubTimestamp":1738679597,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时33分,Genprex, Inc.股票出现异动,股价急速跳水12.31%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.16%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223317a239292e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223317a239292e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2508312834","title":"Genprex, Inc.盘中异动 早盘大幅下挫5.08%报0.587美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508312834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508312834?lang=zh_cn&edition=full","pubTime":"2025-02-04 00:21","pubTimestamp":1738599689,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日00时21分,Genprex, Inc.股票出现异动,股价急速下跌5.08%。截至发稿,该股报0.587美元/股,成交量6.223万股,换手率0.73%,振幅6.13%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.53%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204002129abc11e6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204002129abc11e6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2506951709","title":"Genprex, Inc.盘中异动 股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506951709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506951709?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:24","pubTimestamp":1738077868,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时24分,Genprex, Inc.股票出现异动,股价大幅上涨5.28%。截至发稿,该股报0.640美元/股,成交量5.4322万股,换手率0.64%,振幅8.88%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.18%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282324299612faac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282324299612faac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2506914308","title":"Genprex, Inc.盘中异动 早盘快速下跌7.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506914308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506914308?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:33","pubTimestamp":1737988383,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时33分,Genprex, Inc.股票出现异动,股价急速跳水7.13%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012722330496123997&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012722330496123997&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2505776825","title":"Genprex, Inc.盘中异动 大幅拉升6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505776825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505776825?lang=zh_cn&edition=full","pubTime":"2025-01-23 01:10","pubTimestamp":1737565843,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日01时10分,Genprex, Inc.股票出现波动,股价大幅上涨6.01%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123011044986f9181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123011044986f9181&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2503624061","title":"Genprex, Inc.盘中异动 股价大跌5.15%报0.700美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503624061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503624061?lang=zh_cn&edition=full","pubTime":"2025-01-16 00:42","pubTimestamp":1736959374,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日00时42分,Genprex, Inc.股票出现波动,股价急速跳水5.15%。截至发稿,该股报0.700美元/股,成交量7.8195万股,换手率0.92%,振幅4.66%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.91%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160042549604d31f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160042549604d31f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2501771013","title":"Genprex, Inc.盘中异动 早盘快速下挫5.15%报0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501771013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501771013?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:55","pubTimestamp":1736348139,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时55分,Genprex, Inc.股票出现异动,股价快速跳水5.15%。截至发稿,该股报0.810美元/股,成交量8.7026万股,换手率1.02%,振幅5.14%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.05%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225539985f7d89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225539985f7d89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2501784911","title":"Genprex, Inc.盘中异动 急速下挫6.09%报0.822美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501784911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501784911?lang=zh_cn&edition=full","pubTime":"2025-01-07 23:47","pubTimestamp":1736264875,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日23时47分,Genprex, Inc.股票出现异动,股价快速跳水6.09%。截至发稿,该股报0.822美元/股,成交量6.5406万股,换手率0.77%,振幅5.71%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为1.20%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010723475595fbac3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010723475595fbac3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2501255257","title":"Genprex, Inc.盘中异动 早盘快速上涨5.05%报0.880美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501255257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501255257?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:49","pubTimestamp":1736174989,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时49分,Genprex, Inc.股票出现异动,股价大幅拉升5.05%。截至发稿,该股报0.880美元/股,成交量4.097万股,换手率0.48%,振幅3.92%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106224949a2179ac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106224949a2179ac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2500922526","title":"Genprex, Inc.盘中异动 早盘股价大涨5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500922526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500922526?lang=zh_cn&edition=full","pubTime":"2025-01-02 22:32","pubTimestamp":1735828326,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日22时32分,Genprex, Inc.股票出现异动,股价急速上涨5.82%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.79%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102223206ab9bf63e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102223206ab9bf63e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2500761280","title":"Genprex, Inc.盘中异动 股价大涨5.27%报0.895美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500761280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500761280?lang=zh_cn&edition=full","pubTime":"2024-12-31 23:43","pubTimestamp":1735659806,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日23时43分,Genprex, Inc.股票出现波动,股价大幅上涨5.27%。截至发稿,该股报0.895美元/股,成交量17.4176万股,换手率2.05%,振幅5.22%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.46%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231234326a2109a04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231234326a2109a04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2495528702","title":"Genprex, Inc.盘中异动 早盘急速下挫5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495528702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495528702?lang=zh_cn&edition=full","pubTime":"2024-12-30 22:35","pubTimestamp":1735569336,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日22时35分,Genprex, Inc.股票出现异动,股价大幅下跌5.16%。截至发稿,该股报0.830美元/股,成交量5.1545万股,换手率0.61%,振幅4.42%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.60%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230223536ab982726&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230223536ab982726&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2493660038","title":"Genprex, Inc.盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493660038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493660038?lang=zh_cn&edition=full","pubTime":"2024-12-24 23:04","pubTimestamp":1735052654,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日23时04分,Genprex, Inc.股票出现异动,股价快速跳水5.09%。截至发稿,该股报0.886美元/股,成交量4.6015万股,换手率0.54%,振幅2.02%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.44%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224230415a207c884&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224230415a207c884&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genprex.com","stockEarnings":[{"period":"1week","weight":0.0685},{"period":"1month","weight":-0.2364},{"period":"3month","weight":-0.6868},{"period":"6month","weight":-0.135},{"period":"1year","weight":-0.9127},{"period":"ytd","weight":-0.5734}],"compareEarnings":[{"period":"1week","weight":-0.0228},{"period":"1month","weight":-0.0672},{"period":"3month","weight":-0.0685},{"period":"6month","weight":0.0014},{"period":"1year","weight":0.0929},{"period":"ytd","weight":-0.0397}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Genprex, Inc.于2009年4月在特拉华州注册成立。该公司是一家私人持有的临床阶段生物制药公司,为癌症开发免疫原性治疗。Genprex是一种临床阶段的基因治疗公司,开发一种新的方法来治疗癌症,根据其新的专利技术平台,包括其最初的候选产品,Oncoprex免疫基因治疗提供,或Oncoprex。他们的平台技术旨在通过将其包封在称为纳米囊泡的纳米尺度空心球体中来治疗癌症基因,然后静脉内施用并被肿瘤细胞摄取,其中它们表达缺少或发现量低的蛋白质。 Oncoprex具有多模式作用机制,其中断细胞信号通路,其引起癌细胞的复制和增殖,重新建立癌细胞中凋亡途径或程序性细胞死亡途径,并调节针对癌细胞的免疫应答。 Oncoprex也被证明可以阻断产生耐药性的机制。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.742934},{"month":2,"riseRate":0.428571,"avgChangeRate":0.07738},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.159085},{"month":4,"riseRate":0.285714,"avgChangeRate":0.230015},{"month":5,"riseRate":0.428571,"avgChangeRate":0.02727},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.121366},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.165011},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.112826},{"month":9,"riseRate":0,"avgChangeRate":-0.190311},{"month":10,"riseRate":0.142857,"avgChangeRate":0.561276},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.192128},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.013869}],"exchange":"NASDAQ","name":"Genprex, Inc.","nameEN":"Genprex, Inc."},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.7","shortVersion":"4.31.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Genprex, Inc.,GNPX,Genprex, Inc.股票,Genprex, Inc.股票老虎,Genprex, Inc.股票老虎国际,Genprex, Inc.行情,Genprex, Inc.股票行情,Genprex, Inc.股价,Genprex, Inc.股市,Genprex, Inc.股票价格,Genprex, Inc.股票交易,Genprex, Inc.股票购买,Genprex, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}